CAPRICOR THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2019-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-08-10
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 0.00 shares.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 0.00 shares.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-03-31 was 25.36K shares.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-12-31 was 1.19M shares.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 1.19M shares.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 0.00 shares, a 100.00% decline from fiscal 2011.
- CAPRICOR THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2011 was 1.11M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 0.00 shares 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-15 | |||
| 2014-03-31 | 25.36K shares 10-Q · filed 2014-05-15 | 1.21M shares derived: sum of 2 quarters · filed 2014-05-15 | 1.21M shares derived: sum of 3 quarters · filed 2014-05-15 | 1.21M shares derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-12-31 | 1.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 1.19M shares derived: sum of 2 quarters · filed 2014-03-31 | 1.19M shares derived: sum of 3 quarters · filed 2014-03-31 | 1.19M shares 10-K · filed 2014-03-31 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-14 | 0.00 shares 10-Q · filed 2013-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 0.00 shares 10-Q · filed 2013-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-06-21 | 0.00 shares derived: sum of 2 quarters · filed 2013-06-21 | ||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | 0.00 shares 10-K · filed 2013-06-21 | ||
| 2012-09-30 | 0.00 shares 10-Q · filed 2013-06-21 | |||
| 2011-12-31 | 1.11M shares 10-K · filed 2013-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |